Suncoast Clinical Research, Inc.

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Suncoast Clinical Research, Inc. - overview

Established

1998

Location

New Port Richey, FL, US

Primary Industry

Pharmaceuticals

About

Based in Florida, US, and founded in 1998, Suncoast Clinical Research, Inc. operates as a clinical research organization that provides pharmaceutical research and development services in medical fields. In December 2023, Atlas Clinical Research, LLC, a therapeutically-driven clinical, and portfolio company of Beecken Petty O'Keefe & Company, acquired Suncoast Clinical Research, Inc. As of December 2023, the company operates across two locations in Pasco and Pinellas County.


  Suncoast Clinical Research, Inc. offers comprehensive support with a diverse portfolio including rheumatoid arthritis, diabetes, Alzheimer’s, women's health, endocrinology, pulmonology, and ophthalmology. its multi-therapeutic, community-based research spans a wide spectrum, aiming to enhance patients' lives through its treatments.


Current Investors

Atlas Clinical Research, LLC

Primary Industry

Pharmaceuticals

Sub Industries

Pharmaceutical Research & Development

Website

www.suncoastclinicalresearch.com

Verticals

Manufacturing

Company Stage

Add-on

Total Amount Raised

Subscriber access only

Suncoast Clinical Research, Inc. - deals

Deals TypeDeal StatusTarget (s)Deal DateInvestor(s)Seller(s)Deal size (Mn)Enterprise value (Mn)Post-money valuation (Mn)EBITDA multiple (x)Revenue multiple (x)Lead partner (s)
Add-onCompletedSuncoast Clinical Research, Inc.-

Displaying 1 - 1 of 1

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.